Loading viewer...
investor_presentation
Format: PDF investor_presentation
Fortress Biotech is a clinical-stage biopharmaceutical company with a diversified portfolio spanning dermatology, rare disease, rheumatology, and oncology. The company markets eight dermatology products and develops multiple product candidates across preclinical, clinical, and late-stage development, including gene therapies and CAR-T technologies. Fortress maintains economic interests in majority-owned partners and other affiliated companies with various therapeutic modalities.
presentation
investor_presentation
Element 25 Limited
Australian Strategic Materials Equity Raising Presentation 2021
investor_presentationinvestor_presentation
34 Pages
Australian Strategic Materials Limited